SCHEDULE: Charles Schwab Discloses 5.24% Stake in Accendra Health

Charles Schwab Investment Management Inc. has reported a 5.24% beneficial ownership stake in Accendra Health Inc., holding over 4 million shares of common stock.

Summary

• Charles Schwab Investment Management Inc. has filed a Schedule 13G, disclosing beneficial ownership of common stock in ACCENDRA HEALTH INC/VA/.
• The reporting person, Charles Schwab Investment Management Inc., is an investment adviser organized in Delaware.
• As of December 31, 2025, Charles Schwab Investment Management Inc. beneficially owned 4,057,056 shares of Accendra Health Inc. common stock.
• This ownership represents 5.24% of the class of securities.
• The reporting person holds sole voting power and sole dispositive power over all 4,057,056 shares.
• The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive signal, as it indicates significant institutional interest and a substantial stake held by a reputable investment manager, which can instill investor confidence.

Positives

• A significant institutional investor, Charles Schwab Investment Management Inc., holds a 5.24% stake, which can be viewed as a vote of confidence in Accendra Health Inc.

Negatives

• This filing is an ownership disclosure and does not contain information regarding the operational or financial performance of Accendra Health Inc. that would indicate negatives.

Risks

• This filing is an ownership disclosure and does not detail specific risks related to Accendra Health Inc.'s business operations or financial health.

Future Outlook

This Schedule 13G filing is an ownership disclosure and does not contain any forward-looking statements or guidance regarding Accendra Health Inc.'s future performance or strategic direction.

Management Comments

• Omar Aguilar, Chief Executive Officer of Charles Schwab Investment Management Inc., certified that 'to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11.'

Industry Context

StockSavvy.ai notes that the disclosure of a 5.24% stake by a prominent investment manager like Charles Schwab Investment Management Inc. in Accendra Health Inc. indicates significant institutional interest. Such filings are common for large asset managers as part of their diversified portfolio management, reflecting a standard investment position rather than an activist stance.

Comparison to Industry Standards

• NA This filing is a beneficial ownership report and does not provide performance metrics or operational results for comparison to industry standards or specific comparable companies/projects.

Stakeholder Impact

• Shareholders: The disclosure of a significant institutional holding by Charles Schwab Investment Management Inc. may positively influence investor sentiment and potentially the stock price, signaling confidence from a major player.

Key Dates

Keywords

Accendra Health Inc, Charles Schwab Investment Management, Schedule 13G, Beneficial Ownership, Common Stock, Investment Adviser, Institutional Ownership